You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
邁普醫學(301033.SZ):擬購買易介醫療100%股權
格隆匯 06-05 18:56

格隆匯6月5日丨邁普醫學(301033.SZ)公佈,公司擬通過發行股份及支付現金的方式向澤新醫療等10名交易對方購買易介醫療100%股權,截至本預案簽署日,標的公司的審計、評估工作尚未完成,標的資產評估結果及交易作價尚未確定。

上市公司是一家致力於結合人工合成材料特性,利用先進製造技術開發高性能植入醫療器械的高新技術企業。目前,公司是國內神經外科領域唯一同時擁有人工硬腦(脊)膜補片、顱頜面修補及固定系統、可吸收再生氧化纖維素、硬腦膜醫用膠等植入醫療器械產品的企業,覆蓋開顱手術所需要的關鍵植入醫療器械。標的公司主要從事神經內科領域的泛血管介入醫療器械的研發、設計和銷售,主要產品包括神經介入導管、神經介入導絲、球囊擴張導管等。本次交易完成後,上市公司將進一步拓展產品品類,形成多元化的產品矩陣。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account